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Introduction 
Static lung volume measurements allow objective assessment of total lung capacity (TLC), 
functional residual capacity (FRC) and residual volume (RV), and assist in the diagnosis and 
management of lung disease. [1, 2] The use of gas dilution techniques, such as multiple breath 
nitrogen washout (MBNW), require minimal patient cooperation and allows FRC to be 
determined in those individuals unable to complete plethysmographic measurements. The 
MBNW technique is used clinically and for research, and provides accurate and repeatable 
measures in both children and adults. [3, 4] 
The 2005 American Thoracic Society (ATS) and European Respiratory Society (ERS) 
guidelines recommend a wait between repeated MBNW tests of at least 15 minutes and that in 
obstructed patients a period of >1 hour may be required.[2] 
This study aimed to develop an evidence based recommendation for the wait required 
between repeated MBNW tests using contemporary equipment and standardized collection 
protocols.  
Materials and methods 
Children were tested in the Respiratory Laboratory of Princess Margaret Hospital for Children 
and the adults at the Respiratory Laboratory of Royal Perth Hospital both located in Perth, 
Western Australia. The study was approved by the relevant Ethics Committees (EC 
LR.2008/127 and EC06-91) and written informed consent obtained from all participants 
and/or their parents as relevant.  
The study commenced in children between November 2006 and January 2008 and then 
expanded to the adult population from December 2007 to November 2009. Spirometry was 
only obtained in participants with lung disease according to current guidelines. [5] All 
MBNW tests were conducted according to the 2005 ATS/ERS criteria for the MBNW 
technique.[2]  
Paediatric protocol 
Children attended on a single occasion and were classed as healthy or lung disease, the latter 
including asthma and cystic fibrosis. The initial MBNW (VMax Encore 229: Carefusion, 
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Australia) measurement of FRC was obtained for each child (t=0). Children repeated the FRC 
measurement after waiting 5 minutes, then after waiting a further 15 minutes, or after waiting 
15 minutes then 5 minutes, with testing order randomized.  
Adult protocol 
The adults were classed as healthy, obstructive lung disease or restrictive lung disease. On 
review of the paediatric data, and considering that the time to clear gas from the lungs is 
dependent on disease severity, the protocol for adults was modified such that the time 
between MBNW tests was determined as a multiple of the initial washout time. An initial 
MBNW (Medgraphics Corporation, United States) was performed (t=0) to provide the 
baseline washout time. The measurement was then repeated after waiting once, twice, and 
three times their initial washout time, in randomized order. 
Data Analysis  
Data (mean and standard deviation (SD)) were normally distributed. Lung function is 
presented as predicted standardised residuals. [6-9] We defined acceptable between test 
repeatability as a change in FRC <10%, in line with current MBW testing guidelines.[10] 
Power analysis showed that group sample sizes of 14 would detect a change of 10% assuming 
an σ of 0.35 (CV of 18.75%).  Data were analysed using paired t-tests and a random effects 
longitudinal regression model to assess the change in FRC from baseline.  
Results 
Paediatric data 
Acceptable and repeatable FRC were obtained in 19 healthy children and 18 with lung disease 
(n=8 with asthma and n=10 with cystic fibrosis) aged 7 to 18 (mean (SD) 12.76 (3.18)) years. 
Spirometry in the children with lung disease was -1.48 (1.75) for FEV1, -0.89 (1.13) for FVC 
and -1.21 (1.51) for FEV1/FVC. No clinically (≥10%) or statistically significant differences 
were detected between baseline FRC (FRC0) and after five (FRC5) or 15 (FRC15) minutes in 
either group (Table). These was confirmed using random effects regression modelling with no  
associations between differences in FRC and wait time, test order or disease status.  
Adult data 
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Measurements of FRC were obtained in 24 healthy adults (aged 35 (16.3) years)), 16 adults 
with interstitial lung disease (aged 64.8 (8.6) years)) and 18 adults with chronic obstructive 
pulmonary disease (aged 61.6 (17.1) years)). Mean (SD) spirometry was -1.66 (1.22) for 
FEV1, -1.90 (1.23) for FVC and 0.41 (1.28) for FEV1/FVC in restricted lung disease while 
those with obstructive lung disease had spirometry of -3.17 (1.28), -1.29 (1.16) and -3.30 
(1.36) for FEV1, FVC and FEV1/FVC, respectively. Waiting the initial washout time had no 
effect on FRC in the healthy or restrictive groups. The obstructive lung disease group 
exhibited a clinically significant fall in FRC of 360 mL (-10.2%; p<0.001) after waiting one 
times the washout time (Table). This effect was not evident with longer wait times (Table). 
Random effects regression analysis indicated that obstructive disease severity (assessed by 
FEV1/FVC) had no effect (p=0.98) on the change in FRC between measurements. Similarly, 
restrictive disease severity (assessed by predicted TLC) also had no effect (p=0.69) on FRC. 
Discussion 
This study investigated the time required for nitrogen levels in the lungs to return to baseline 
following repeated MBNW testing thereby avoiding the introduction of measurement errors. 
To increase the generalizability of our findings, both children and adults were included, with 
varying degrees of lung disease severity.  
In children we found that waiting 5 minutes (an average of 2.6 times the initial washout time) 
between measurements allowed nitrogen to return to baseline. In healthy adults and in adults 
with restrictive lung disease, a wait time of a single washout was sufficient for nitrogen to 
return to baseline. In adults with obstructive lung disease, a period of twice their initial 
washout time was required to measure FRC with acceptable repeatability. Nonetheless, 
waiting twice the initial washout time was, on average, 5.5 minutes and significantly shorter 
than the 15 to 60 minutes recommendation in the 2005 ATS/ERS guidelines. Previous infant 
MBW testing guidelines [11] and the 2013 ATS/ERS MBW consensus statement [10] 
recommend that a wait time of at least twice the washout period be used, and these data 
support that recommendation. 
 5 
The study does have limitations. The protocol differed between adult and paediatric groups, 
with the adult protocol informed by the paediatric data. We do not believe this alters our 
recommendations as the children had a mean wait time of 2.6 times the initial washout time 
which is in line with our recommendation of waiting at least twice the initial washout time in 
adults. This is further supported by the fact that the adults had more severe obstruction and 
therefore the likelihood that twice the washout time not being adequate in children is low. It 
should be acknowledged that patients with more severe lung disease that those in this study 
may require longer wait times and the observation of alveolar nitrogen levels prior to testing 
commencing, as recently recommended [10], would increase certainty around test 
commencement. We were not able to measure lung clearance index (LCI). However, errors 
that affect FRC will also impact LCI and we suggest that studies using ventilation distribution 
outcomes incorporate these findings into the measurement protocols.  
In conclusion, we recommend a uniform approach to wait time between MBNW tests and to 
wait at least twice the initial washout time and to monitor post-test nitrogen levels before 
repeating the MBNW measurement. Further studies should examine further optimising these 
recommendations for all MBW outcomes. We believe our recommendation should inform 
lung function testing practices in paediatric and adult settings and will help optimize the 
quality of lung volume measurements. 
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TABLE 1: Impact of waiting times on repeat measurements of FRC in children and adults 
                              Children 
  
 
FRC0 SR   FRC0 
 
FRC5 
 
FRC15 
  Healthy n=19 -0.65 (0.77) 
 
1.90 (0.57) 
 
0.09 (0.22) 
 
0.01 (0.15) 
  
           With lung disease n=18 -0.47 (1.64) 
 
1.54 (0.45) 
 
0.01 (0.13) 
 
0.03 (0.11) 
  
           Adults 
 
FRC0 SR   FRC0 
 
FRC1x 
 
FRC2x 
 
FRC3x 
Healthy n=24 -0.66 (1.44) 
 
2.90 (0.76) 
 
-0.08 (0.22) 
 
-0.03 (0.44) 
 
0.03 (0.31) 
           Restrictive disease n=16 -2.02 (0.62) 
 
1.99 (0.42) 
 
-0.07 (0.20) 
 
-0.11 (0.27) 
 
-0.03 (0.19) 
           Obstructive disease n=18 1.56 (2.23) 
 
3.69 (1.03) 
 
-0.36 (0.44)# 
 
0.01 (0.29) 
 
-0.15 (0.46) 
 
Legend: Baseline FRC (FRC0) is FRC measured at time 0 and is reported in absolute values (in litres) and predicted standardised residuals (FRC0 SR) (T0)); 
FRC5 and FRC15 measured after 5 and 15 minutes. FRC1x, FRC2x and FRC3x equates to FRC measured after waiting at 1, 2 and 3 times the initial washout 
time. Data presented as mean and standard deviation (mean (SD)). The difference (in FRC (in litres) from baseline is presented as the mean (SD) 
difference from FRC0. Adults with obstructive lung disease had a significantly lower (p<0.001) FRC at FRC1x compared to FRC0, there were no other 
clinically or statistically differences in children or adults at any other time point. 
 
 
 
 
